Loading provider…
Loading provider…
Ophthalmology Physician in Bellaire, TX
NPI: 1205817764Primary Practice Location
Richard W Yee MD PLLC
5555 W Loop S Fwy, Bellaire, TX
Primary Employer
Richard W Yee MD PLLC
drrichardyee.com
HQ Phone
Get MD Richard's Phone Numberphone_androidMobile
Get MD Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1979 - 2027
OK State Medical License
2020 - 2021
WI State Medical License
1983 - 1987

American Board of Ophthalmology
Ophthalmology
Medical College Of Wisconsin
mcw.edu
Fellowship • Cornea
Until 1983
Residency • Ophthalmology
1984 - 1985
Dell Medical School
dellmed.utexas.edu
Internship • Transitional Year
1979 - 1980
Joe R. & Teresa Lozano Long School of Medicine
uthscsa.edu
Medical School
Until 1979
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Residency • Ophthalmology
1981 - 1983
University of Texas Medical Branch Hospitals/Methodist Hospital (Houston)
Residency • Ophthalmology
1980 - 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 182 | 238 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 181 | 403 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 53 | 53 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 42 | 44 |
| 5 | 68761Closure of tear duct opening using plug | 41 | 44 |
Authors: Elena Kiang
Journal: J Cataract Refract Surg
Use of impression cytology in neonatal chlamydial conjunctivitis.
Authors: Steven Maskin
Journal: Arch Ophthalmol
Lead Sponsor: Richard W Yee, MD
Intervention / Treatment: DRUG: Placebo, DRUG: Topical spironolactone ophthalmic solution, 0.005 mg/cc
Lead Sponsor: Richard W Yee, MD
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Lifitegrast 5% Ophthalmic Solution